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Abstract
Background: To evaluate the effect of bradykinin (BK) on TGF-β1-induced retinal pigment epithelial (RPE) cell
proliferation and extracellular matrix secretion and to elucidate the relationship between BK and the Erk/Akt
signaling pathway.
Methods: The effects of BK on TGF-β1-induced RPE cell proliferation were examined via CCK-8 assay. Cell culture
supernatant collagen I concentrations were measured via ELISA. Fibronectin (Fn), matrix metalloproteinase-2
(MMP-2) and MMP-9 mRNA and protein expression levels were measured via q-PCR and Western blotting, respectively.
Changes in Akt/Erk phosphorylation induced by BK and HOE-140 were evaluated via Western blotting.
Results: TGF-β1 stimulated ARPE-19 cell proliferation, which was inhibited by BK, whose effects were inhibited by
HOE-140. BK inhibited TGF-β1-induced collagen I, Fn and MMP-2 secretion in RPE cells, and these effects were
inhibited by HOE-140. BK also inhibited TGF-β1-induced Akt phosphorylation in RPE cells, and these effects were
blocked by HOE-140. BK had no significant effect on Erk-mediated signaling.
Conclusions: The findings from this study indicate that BK could be novel therapeutic targets for the treatment
of PVR.
Keywords: Proliferative vitreoretinopathy, Retinal pigment epithelium, Bradykinin, Transforming growth factor-β1,
Extracellular matrix
Background
Proliferative vitreoretinopathy (PVR) is the most com-
mon cause of failed repair of rhegmatogenous retinal de-
tachment [1]. The major feature of PVR is the formation
of a subretinal or epiretinal membrane (ERM) that con-
sists of retinal pigment epithelial (RPE) cells, fibroblasts,
glial cells, and macrophages, as well as extracellular
matrix [2]. Besides, concomitant inflammatory cells are
involved in the formation of proliferative membrane [3].
The pathogenesis of PVR includes migration of cells,
proliferation of migrating cells, membrane development,
contraction, extracellular collagen production and creation
of fixed folds in the retina [4].
Under physiological conditions, RPE cells exist in a
resting state and remain in G0 phase, which maintains
normal retinal function. Human RPE (hRPE) cells are
frequently used in in vitro studies to investigate RPE-
related disesases, as well as specific clinical treatments
for these diseases. Thus, the hRPE cell line ARPE-19 was
used in our study [2, 5, 6].
Previous studies have reported that abnormal ECM de-
position and cell proliferation increase the likelihood of
PVR development, and the newly formative ECM promotes
membrane contraction. Therefore, preventing abnormal
ECM deposition and cell proliferation may prevent PVR
development [3, 7]. Collagen is the most abundant protein
in the human body and comprises several different sub-
types. Types I and III contribute to PVR membrane
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formation [8], which results in RPE cell phenotype changes,
as well as RPE cell proliferation, migration and deform-
ation [9]. Fibronectin (FN), laminin (LN) and vitronectin
(VN) are the major components of non-collagenous gly-
coproteins. Previous studies have shown that FN influences
specific RPE cell behaviors, including trans-differentiation,
proliferation, migration, adhesion, contraction and cytoskel-
etal formation [10].
The balance between ECM production and degradation
is tightly regulated, and matrix metalloproteinases (MMPs)
are associated with the degradation of collagen and other
ECM proteins [11]. Other studies have shown that MMP
activity correlates with PVR membrane formation [12].
Some studies have shown that MMP-1 exists in the normal
retina, while MMP-2 and MMP-9 exist in the epiretinal
and subretinal membranes and facilitate cell migration to
the vitreous cavity in the setting of early PVR [13, 14].
Gonzalez-Avila noted obvious increases in MMP-2 and
MMP-9 expression in the subretinal fluid of PVR patients
[15]. MMPs play an important role in regulating ECM
remodeling.
In PVR, ECM synthesis, secretion and degeneration are
stimulated not only by MMPs but also by growth factors,
especially TGF-β1. Dvashi et al. find that TGF-β1 Induces
Transdifferentiation of RPE Cell via TAK1 pathway [16].
TGF-β1 stimulates RPE cell type I, III and IV collagen ex-
pression [17, 18]. Previous studies have found that inhibit-
ing TGF-β1 expression may prevent PVR progression
[19]. TGF-β1 plays a vital role in PVR formation, as it
regulates cell proliferation, promotes ECM synthesis
and induces ECM deposition at wound sites, resulting
in scarring and fibrosis [8, 20].
The kallikrein-kinin system (KKS) is one of the main
pressure-releasing systems in the human body, which
comprises kininogen (KNG), kinin, kininase, kallikrein,
kallikrein and kinin receptors, also plays a role in PVR
progression [21]. Some studies found that KKS had the
pro-inflammatory effects [22] and increased the perme-
ability of the retinal microvasculature [23]. But the effect
of BK on the process of PVR is controversial. So we
focus on KKS, which modulates several important func-
tions, in order to find new therapies to PVR. Bradykinin
(BK) is the primary determinant of KKS activity [24].
Our previous studies have shown that KNG1 is localized
in the vitreous body and that its expression is positively
correlated with PVR severity [25, 26]. High levels of BK
expression have been detected in the serum, vitreous
body and retina of PVR rats, which indicates that BK
may be associated with PVR development [21]. Nelly
Blaes reported that BK inhibits TGF-β-induced collagen
production by activating the bradykinin B2 receptor
(B2R) [27]. Other studies have found that BK inhibits
growth factor-induced cell proliferation and ECM secre-
tion [28]. However, the effects of BK on cultured RPE
cell proliferation and the mechanism underlying its ef-
fects on TGF-β1 remain unknown. Therefore, we inves-
tigated the effect of BK on TGF-β1-induced RPE cell
proliferation and extracellular matrix secretion.
Methods
Reagents and antibodies
BK and anti-MMP-2 antibodies were obtained from Abcam
(Cambridge, UK). The BK B2 receptor-specific antagonist,
HOE-140, was purchased from Shanghai Top-Peptide
Biotechnology Company (Shanghai, China). Recombinant
human TGF-β1 was obtained from PeproTech Inc.
(New Jersey, USA). Antibodies to fibronectin, Akt, and
phosphorylated Akt (p-Akt) were purchased from Bio-
world (Minnesota, USA), and antibodies to p-Erk1/2
and anti-MMP-9 were obtained from Cell Signaling
Technology (Boston, USA).
Cell culture and general experimental methods
ARPE-19 cells (ICell Bioscience, China) were used for
the experiments and were cultured in 10 % fetal bovine
serum (FBS)-supplemented (Gibco, USA) DMEM/F12
culture medium (Hyclone, USA) at 37 °C in a humidified
atmosphere of 5 % CO2. The experiments were performed
using cultured ARPE-19 cells (passages two through four)
that were grown until they exhibited a hexagonal shape
and no visible pigmentation. Upon reaching 60–70 %
confluence, the ARPE-19 cells were cultured for 24 h in
FBS-free DMEM/F12 culture medium to achieve cell
synchronization. We treated the cells with four different
interventions. The cells were incubated with 0.1, 0.5, 2.5,
10, 12.5 ng/ml TGF-β1 and 0.1, 1, 10, 100, 1000 nM BK
for 24 and 48 h. Cell Counting Kit-8 (CCK-8) (Beijing
Zoman Biotechnology Co., Ltd., China) was applied to
detect cell proliferation. In addition, after the ARPE-19
cells were pre-incubated with various concentrations
(0.1, 1, 10, 100, 1000 nM) of BK for 30 min, they were
coincubated with 10 ng/ml TGF-β1 for 24 and 48 h so
that we could observe the effect of BK on TGF-β1-
induced ARPE-19 cell proliferation. We pre-incubated
the cells with 1 μM HOE-140 for 30 min before treat-
ing them with or without exogenous TGF-β1 and BK.
Cell proliferation detection by CCK-8
ARPE-19 cells were diluted and suspended in complete
culture medium containing 10 % FBS before being plated
at a density of 2000 cells/well (100 μl/well) in 96-well
plates for 24 h. The cells were starved in basal medium
without FBS for 12 h to achieve synchronization. After be-
ing treated with the above different interventions, the cells
were cultured for 24 and 48 h and then coincubated with
10 μl of CCK-8/well at 37 °C in the dark for 3 h. Optical
density (OD) was detected at 450 nm using a microplate
reader. Each group had five parallel wells, and detection
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was repeated three times per group to obtain mean values,
which were used for subsequent statistical analyses.
Type I collagen ELISA
Cell supernatant type I collagen (Col I) secretion was
assessed using a human Col I enzyme-linked immuno-
sorbent assay (ELISA) kit (Shanghai Senxiong Company,
China), according to the manufacturer’s instruction.
Cells were seeded in 6-well plates at a density of 2 × 105
cells/well and treated with five different interventions.
The control group was incubated with phosphate-buffered
saline (PBS), the BK group was incubated with 1 nM BK,
the TGF-β1 group was incubated with 10 ng/ml TGF-β1,
and the BK and TGF-β1 group was pre-incubated with 1
nM BK for 30 min before being treated with 10 ng/ml
TGF-β1. The HOE-140, BK and TGF-β1 group was pre-
incubated with 1 μM HOE-140 and 1 nM BK for 30 min
each before being treated with 10 ng/ml TGF-β1. All
groups were cultured for 48 h after the above interven-
tions. Their supernatants were subsequently collected and
centrifuged. Col I concentrations were measured at
492 nm and calculated from a standard curve.
Q-PCR for fibronectin, MMP-2, and MMP-9 mRNA
expression measurements
q-PCR was used to measure mRNA expression. Total
RNA was extracted using Trizol (Invitrogen, USA). After
incubation, the cells were washed with PBS and treated
with 1 ml of Trizol before being centrifuged for 5 min.
Chloroform (Shanghai Generay Biotech Co., Ltd, China)
was added (200 μl of chloroform/ml Trizol) to the reac-
tion tube, which was shaken vigorously, incubated for
5 min and centrifuged at 12000 rpm for 15 min. The
aqueous fluid was then removed from the tube and placed
in another centrifuge tube, mixed with isopropanol
(Shanghai Generay Biotech Co., Ltd, China) (500 μl
isopropanol/ml Trizol), incubated for 10 min, and centri-
fuged at 12000 rpm for 10 min for RNA precipitation.
The mixture was then dried using anhydrous ethanol be-
fore being treated with 30 μl of DEPC (Sigma, USA) water
to dissolve the RNA precipitate. The RNA concentration
was subsequently detected via spectrophotometry with an
A260/280 ratio of 1.8–2.0.
cDNA was synthesized via RT-PCR (TaKaRa, Japan),
according to the manufacturer's protocol. cDNA was
amplified with specific primers. GAPDH primers were
used as controls. The nucleotide sequences of fibronectin,
MMP-2, MMP-9 were obtained from GenBank and used
to design specific primers (synthesized by Sangon Corpor-
ation, Shanghai, China), the sequences of which are shown
in Table 1. A total of 0.5 μl of reverse-transcribed cDNA
was subjected to PCR in the presence of 10 μl of PCR mix
and 0.5 μl of sense and antisense primers. q-PCR was used
to detect Fn, MMP-2, and MMP-9 mRNA expression.
Relative mRNA expression levels were calculated as
the difference between target and reference gene (GAPDH)
expression levels using the ΔCT method. Real-time PCR
was performed in triplicate for each gene, including
GAPDH. The threshold cycles at which exponential in-
creases in PCR product amplification were detected
were used for quantification.
Western blot analysis
Fibronectin, MMP-2 and MMP-9 protein expression
levels were detected by Western blotting. Cold radio-
immunoprecipitation assay (RIPA) buffer and phenylmethyl-
sulfonyl fluoride (PMSF: a protease inhibitor) (Shanghai
Beyotime Biotech Co., China) were used to lyse the cells,
which were washed twice with PBS. A cell scraper was used
to gather the cell lysates, which were subsequently
transferred to Eppendorf tubes and centrifuged for 30 min
at 12,000 rpm (4 °C) to obtain the supernatants. A BCA
protein assay kit (Shanghai Beyotime Biotech Co., China)
was used to determine protein concentrations. Protein
samples (30 μg protein/well) were electrophoresed via so-
dium dodecyl sulfate polyacrylamide gel electrophoresis
(SDS-PAGE) and then transferred to polyvinylidene
difluoride (PVDF) membranes, which were sequentially
blocked in Tris-buffered saline containing 5 % milk for 1 h
at 37 °C, incubated with antibodies to fibronectin, MMP-2
and MMP-9 overnight, washed, and then incubated with
the appropriate secondary antibody for 1 h at 37 °C. Band
densities were quantified using Image J software.
Akt, Erk 1 and 2 expression levels were measured by
Western blotting, as described above. The cells were in-
cubated with BK, TGF-β1 and the BK receptor antagon-
ist HOE-140 to determine the effect of HOE-140 on Akt
and Erk 1 and 2 phosphorylation.
Statistical analysis
Statistical analyses were performed with SPSS 19.0 soft-
ware. All measurement data were representative of at least
3 separate experiments, are expressed as the mean ± stand-
ard deviation (SD) and were compared between two
groups using Student’s t-test. For multiple comparisons,
the results were analyzed using one-way ANOVA. P-values
less than 0.05 were considered significant.
Table 1 RT-qPCR primers
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Results
The effects of TGF-β1, BK and HOE-140 on APRE-19 cell
proliferation
TGF-β1 stimulated cell proliferation
TGF-β1 promoted cell proliferation at 24 and 48 h. Cell
proliferation was positively correlated with TGF-β1 con-
centrations, with the exception of 12.5 ng/ml. Cell prolif-
eration was significantly increased after 48 h of incubation
compared with 24 h of incubation (Fig. 1a).
BK had no direct effect on cell proliferation
ARPE-19 cells were treated with different BK concentra-
tions for 24 h and 48 h; however, no significant differences
in OD values were noted between the BK-treated group
and the control group (0 nM BK) (P > 0.05).
BK inhibited TGF-β1-induced cell proliferation through B2R
activation
Our previous study demonstrated that 10 ng/ml TGF-β1
increases cell proliferation (P < 0.05). ARPE-19 cells were
pre-incubated with different BK concentrations for 30 min.
BK inhibited TGF-β1-induced cell proliferation, especially
at a concentration of 1 nM (Fig. 1b). Before the cells were
pre-incubated with 1 nM BK, they were incubated with
1 μM HOE-140 for 30 min. HOE-140 prevented the in-
hibition TGF-β1-induced cell proliferation facilitated by
BK (P = 0.003, Fig. 1c).
The effects of BK, HOE-140 and TGF-β1 on ARPE-19 cell
collagen 1 section
A single application of 10 ng/ml TGF-β1 promoted Col
I secretion in ARPE-19 cells (P = 0.005), while a single
application of BK had no significant effect on Col I secre-
tion. TGF-β1-induced Col I secretion was significantly
Fig. 1 a Effect of 24 and 48 h of TGF-β1 stimulation on RPE cell proliferation. **P < 0.01, ***P < 0.001, ****P < 0.0001 versus the OD value of cells
cultured without TGF-β1. b Effect of BK on TGF-β1-induced cell proliferation. & P < 0.05, &&& P < 0.001 versus without TGF-β1 and BK. ***P < 0.001
versus TGF-β1 without BK. c Effect of HOE-140 on the inhibitory effects of BK. **P < 0.01, ***P < 0.001 versus without addition, &P < 0.01 versus with
TGF-β1 alone, #P < 0.01 versus with TGF-β1 and BK
Fig. 2 Effect of BK, HOE-140 and TGF-β1 on Col I secretion in RPE
cells. ** P < 0.01 versus without addition, ****P < 0.0001 versus with
TGF-β1 alone, *P < 0.05 versus with BK and TGF-β1
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inhibited (compared to PBS alone group) when the cells were
pre-incubated with BK before being treated with TGF-β1
(P < 0.0001). HOE-140 blocked the effects of BK on TGF-
β1-induced Col I secretion (P < 0.05), as shown in Fig. 2.
The effects of BK, HOE-140 and TGF-β1 on Fn, MMP-2 and
MMP-9 mRNA expression in ARPE-19 cells
TGF-β1-treated ARPE-19 cells exhibited increased Fn
and MMP-2 mRNA expression compared with control
cells (both P < 0.05); however, a single application of BK
had no significant effects on Fn or MMP-2 mRNA ex-
pression (P > 0.05). BK administration prior to TGF-β1
treatment inhibited TGF-β1-induced increases in Fn and
MMP-2 mRNA expression (both P < 0.05). HOE-140
blocked the effects of BK on TGF-β1-induced Fn and
MMP-2 mRNA expression (both P < 0.05), as shown in
Fig. 3. The expression levels of MMP-9 in each of the
six groups were low; thus, comparisons among these
groups were not performed.
The effects of BK, HOE-140 and TGF-β1 on Fn and MMP
expression in ARPE-19 cells
Western blotting was performed to verify the above-
mentioned q-PCR results. As shown in Fig. 4, TGF-β1
Fig. 3 Effect of BK, HOE-140 and TGF-β1 on fibronectin and MMP-2 mRNA expression in RPE cells. *P < 0.05, *** P < 0.001 versus without addition.
&& P < 0.01, &&& P < 0.001 versus with TGF-β1 alone. #P < 0.05 versus with BK and TGF-β1
Fig. 4 Effect of BK on TGF-β1-induced Fn and MMP-2 protein expression in RPE cells. a Western blotting results for Fn and MMP-2 protein expression
in five groups. b/c TGF-β1 promoted Fn and MMP-2 secretion, which was inhibited by BK. HOE-140 blocked the inhibitory effects of BK. *P < 0.05 versus
without addition. &&P < 0.01 versus with TGF-β1 alone. #P < 0.05 versus with BK and TGF-β1
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promoted Fn and MMP-2 secretion by ARPE-19 cells,
BK inhibited Fn and MMP-2 section, and HOE-140
blocked these effects (all P < 0.05). Therefore, the
Western blotting results were consistent the above-
mentioned q-PCR results.
The effects of BK on Akt and Erk1/2 phosphorylation
BK promoted Akt and Erk1/2 phosphorylation
BK promoted Akt and Erk1/2 phosphorylation in RPE
cells. Akt phosphorylation levels increased most sig-
nificantly after 1 min of BK stimulation, and Erk phos-
phorylation levels increased most significantly after
5 min of BK stimulation (both P < 0.05), as shown in
Fig. 5. BK increased Akt and Erk1/2 phosphorylation
levels over 1 and 5 min in a concentration-dependent
manner in treated ARPE-19 cells compared with con-
trol cells (Fig. 6a, b).
BK inhibited TGF-β1-induced Akt phosphorylation
TGF-β1 significantly increased Akt phosphorylation levels
in treated ARPE-19 cells compared with control cells (P <
0.05); however, pre-incubation with BK inhibited these ef-
fects, as shown in Fig. 7a. However, BK administration
had no significant effects on TGF-β1-induced Erk1/2
phosphorylation (P > 0.05), as shown in Fig. 7b.
BK inhibited TGF-β1-induced Akt phosphorylation via the
BK B2 receptor
To determine the mechanism underlying BK activity, cells
were treated with HOE-140, a BK B2 receptor antagonist,
before being treated with BK and TGF-β1. HOE-140 sig-
nificantly inhibited the effects of BK on TGF-β1-induced
Akt phosphorylation, indicating that the BK B2 receptor
plays a role in inhibiting Akt phosphorylation (Fig. 7a).
HOE-140 did not affect Erk1/2 phosphorylation (Fig. 7b).
Fig. 5 Effect of 100 nM BK on Akt and Erk1/2 phosphorylation in RPE cells during different periods. a Western blotting results for Akt and Erk1/2
phosphorylation during different periods. b Akt phosphorylation levels increased most significantly after 1 min of BK stimulation. c/d Erk1/2
phosphorylation levels increased most significantly after 5 min of BK stimulation. *P < 0.05, ** P < 0.01, **** P < 0.0001 versus with 0 min
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Discussion
Proliferative vitreoretinopathy (PVR) is a complication
that can follow rhegmatogenous retinal detachments.
Proliferative membrane contraction can result in re-
duced vision or blindness [1]. ECM deposition and cell
proliferation are associated with PVR development, how-
ever, the mechanism underlying the relationship between
ECM deposition and cell proliferation and PVR devel-
opment is unclear. The KKS is one of the main
pressure-releasing systems in the human body, and BK
is the primary determinant of KKS activity and thus
plays a vital role in regulating inflammation, cell prolif-
eration, and matrix hyperplasia. The present study
attempted to elucidate the mechanism by which BK
protects against PVR development. Multiple types of
cells and cytokines are involved in the pathogenesis of
PVR, and TGF-β1-induced cell proliferation is closely
related to PVR development.
Many scholars believe that inhibiting cell proliferation
may prevent or delay PVR onset and progression. In this
study, we performed CCK-8 assay to detect RPE cell
proliferation, as this assay is an indicator of cell viability.
We determined that TGF-β1 stimulates RPE cell prolif-
eration and that although BK exerts no direct effects on
cell proliferation, it can affect cell proliferation by sig-
nificantly inhibiting the effects of TGF-β1. In addition,
HOE-140, a bradykinin B2 receptor antagonist, blocked
the effects of BK on TGF-β1. Therefore, this study
demonstrated that BK regulates TGF-β1-induced RPE
cell proliferation by activating the BK B2R.
TGF-β1 is an important regulator of ECM synthesis
and degradation, as well as fibrosis [29, 30]. Connor
showed that PVR patients exhibit significant increases in
their vitreous fluid TGF-β concentrations and that these
Fig. 6 Effect of different concentrations of BK on Akt and Erk1/2
phosphorylation in RPE cells. a Akt phosphorylation levels
increased most significantly after 1 min of BK stimulation. b Erk1/2
phosphorylation levels increased most significantly after 5 min of
BK stimulation. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001
versus with 0 nM BK
Fig. 7 a Effect of BK on TGF-β1-induced Akt phosphorylation in RPE
cells. a TGF-β1 facilitated significant increases in Akt phosphorylation
levels in treated RPE cells compared to control cells; however, this
effect was inhibited via incubation with BK before TGF-β1 treatment
but could be blocked by HOE-140. b Neither BK nor HOE-140 had
an effect on TGF-β1-induced Erk1/2 phosphorylation. *P < 0.05 versus
without addition, && P < 0.01 versus with TGF-β1 alone. ####P < 0.0001
versus with BK and TGF-β1
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increases are directly proportional to PVR severity [31].
Baudouin noted increased TGF-β1 concentrations in
subretinal fluid samples that were collected during dif-
ferent PVR periods. These findings indicate that TGF-β1
plays a role in PVR development and that inhibiting
TGF-β1 expression may prevent PVR development [32].
Obeta reported that TGF-β1 activates Smad-dependent
and Smad-independent signaling by binding TGF-β recep-
tors. The Smad-independent signaling pathways comprise
the PI3K-Akt, mitogen-activated protein kinase (MAPK),
and JNK/p38 pathways, as well as other pathways [33].
The extracellular signal-related kinase1/2 (Erk1/2) sig-
naling pathway is one of the most important signaling
pathways associated with MAPK activity, which can be
activated via phosphorylation cascade stimulation to
regulate cell proliferation and differentiation [34]. PI3K
plays a role in cell proliferation and differentiation and
has been shown to regulate proto-oncogene expression.
PI3K/Akt (also known as protein kinase B, PKB) signal-
ing plays an important role in cell proliferation and sur-
vival [35].
Previous studies have shown that BK increases vascular
smooth muscle cell proliferation by activating the Erk sig-
naling pathway and that BK may also play a role in colla-
gen synthesis and secretion by inhibiting TGF-β-induced
Akt phosphoylation [27].
In the present study, ARPE-19 cells were stimulated
by TGF-β1 and then treated with HOE-140 to determine
the effect of BK on TGF-β1-induced ECM and MMP se-
cretion by ARPE-19 cells, elucidate the mechanism under-
lying this effect, and clarify the relationship between BK
and Akt/MAPK (Erk1/2) signaling. We found that BK
inhibited TGF-β1-induced ECM deposition and MMP se-
cretion. Moreover, TGF-β-induced Akt phosphorylation
was also inhibited by BK. This inhibition was blocked by
HOE-140, indicating that BK inhibits the effects of TGF-
β1. The BK B2R is a G protein-coupled receptor (GPCR),
and the mechanism underlying the effects of BK may in-
volve protein-protein interactions between GPCRs and
TGF-β receptors. Additional in-depth studies must be per-
formed to identify the intracellular signaling pathways and
specific protein-protein interactions associated with the
effects of BK.
This study had some limitations. First, the KKS system
is complicated. Although BK is the primary determinant
of KKS activity, other substances in the KKS system may
also have an impact on collagen formation in RPE cells.
Second, our study involved only cultured RPE cells. We
did not establish an animal model. Third, our study ex-
plored the effects of BK on TGF-β1-induced RPE cell
proliferation; however, in the process of PVR, there are
many growth factors such as transforming growth factor,
hepatocyte growth factor, insulin-like growth factor and
so on. A variety of growth factors are involved in the
process of PVR, cell function changes stimulated by
different growth factors may lead to changes in down-
stream effector molecules. Thus, additional studies must
investigate the effects of BK under different conditions
and the mechanism underlying these effects.
In conclusion, this study showed that BK affects cell
proliferation and ECM secretion and has shed new light
on the mechanisms underlying PVR development, which
may facilitate the development of new therapies for this
disease.
Conclusions
BK exerts its effects by binding the BK B2R in TGF-β1-
treated RPE cells and was found to inhibit TGF-β1-in-
duced cell proliferation. BK inhibited TGF-β1-induced Fn,
collagen I and MMP-2 secretion and Akt phosphoryl-
ation. The findings from this study indicate that BK
could be novel therapeutic targets for the treatment of
PVR.
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